Skip to main content
. 2022 Jun 10;23:32–37. doi: 10.1016/j.phro.2022.06.003

Table 2.

Patient and tumour characteristics.

N = 7
Gender Male 6 (86%)
Female 1 (14%)
Age 61.3 yrs (Range 37–74)
T stage T3a 1 (14%)
T3b 1 (14%)
T3c 3 (43%)
T4 2 (29%)
N Stage N1 5 (71%)
N2 2 (29%)
M Stage M0 7 (100%)
CRM involved Yes 5 (71%)
No 2 (29%)
EMVI present Yes 7 (100%)
Mandard response post treatment TRG 1 3 (43%)
TRG 2 2 (29%)
TRG 3 2 (29%)